In patients without risk factors who are aged 40-45, how often should cholesterol screening be performed?

Prepare for the NBME Form 9 Test with our engaging quiz. Utilize multiple choice questions and explanations. Excel in your exam with thorough study tools and resources!

Multiple Choice

In patients without risk factors who are aged 40-45, how often should cholesterol screening be performed?

Explanation:
Screening intervals for lipids are guided by overall risk. In adults without risk factors, a lipid panel that is normal at baseline can be repeated less frequently because dyslipidemia tends to develop slowly and the yield of frequent testing is low. Therefore, if a patient aged 40–45 has no risk factors and a normal result, rechecking lipids about every 10 years is a reasonable balance between catching emerging risk and avoiding unnecessary testing. If initial results are abnormal or new risk factors appear (smoking, hypertension, diabetes, family history of premature ASCVD, obesity), the follow-up interval should be shorter and management of lipids considered. Testing more often than every few years without new risk factors doesn’t add meaningful benefit here, and never screening would miss gradual changes in lipid status.

Screening intervals for lipids are guided by overall risk. In adults without risk factors, a lipid panel that is normal at baseline can be repeated less frequently because dyslipidemia tends to develop slowly and the yield of frequent testing is low. Therefore, if a patient aged 40–45 has no risk factors and a normal result, rechecking lipids about every 10 years is a reasonable balance between catching emerging risk and avoiding unnecessary testing. If initial results are abnormal or new risk factors appear (smoking, hypertension, diabetes, family history of premature ASCVD, obesity), the follow-up interval should be shorter and management of lipids considered. Testing more often than every few years without new risk factors doesn’t add meaningful benefit here, and never screening would miss gradual changes in lipid status.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy